Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1638-1646
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1638
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1638
Table 2 Antibiotic susceptibility and resistance profile of bacteria
| Antibiotic | Escherichia coli (n = 312) (%) | Pseudomonas aeruginosa (n = 74) (%) | Klebsiella pneumoniae (n = 85) (%) | Enterococcus faecium (n = 51) (%) |
| Ceftriaxone | 251 (80.45%) | 58 (78.38%) | 61 (71.76%) | NA |
| Ampicillin | 277 (88.78%) | 74 (100%) | 81 (95.29%) | 37 (72.55%) |
| Piperacillin/tazobactam | 37 (11.86%) | 9 (12.16%) | 18 (21.18%) | 28 (54.90%) |
| Quinolones | 204 (65.38%) | 11 (14.86%) | 34 (40.00%) | 34 (66.67%) |
| Carbapenems | 0 (0%) | 17 (22.97%) | 2 (2.35%) | NA |
| Vancomycin | NA | NA | NA | 0 (0%) |
| Gentamicin | 144 (46.15%) | 9 (12.16%) | 43 (50.59%) | 18 (35.29%) |
| Linezolid | NA | NA | NA | 0 (0%) |
- Citation: Gu XX, Zhang MP, Zhao YF, Huang GM. Clinical and microbiological characteristics of patients with biliary disease. World J Gastroenterol 2020; 26(14): 1638-1646
- URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1638